Fiomi Diagnostics AB develops and manufacture Meritas® POC Analyzer

http://www.meritaspoc.com/

With its current and future menu of tests, sets a new standard for point-of-care testing, including the only guideline- compliant POC Troponin assay – the Meritas® Troponin I test. This allows fast, cost-effective and accurate triage, enabling rapid intervention for improved patient outcomes. 

Fiomi Diagnostics AB is a wholy owned subsidiary of Trinity Biotech plc. 
Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.


Contact us at
Fiomi Diagnostics AB
Dag Hammarskjölds väg 52A
SE-751 83 Uppsala
Sweden

Dag Hammarskjölds väg 52A


Tel; +46 18 56 08 90 
Fax; +46 18 55 20 90